Reduced penetrance in hereditary motor neuropathy caused by TRPV4 Arg269Cys mutation

José Berciano1, Jonathan Baets, Elena Gallardo

  • 1Service of Neurology, University Hospital "Marqués de Valdecilla" (IFIMAV), "Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas" (CIBERNED), University of Cantabria (UC), 39008 Santander, Spain. jaberciano@humv.es

Journal of Neurology
|February 22, 2011
PubMed

Insights

Reduced penetrance of Charcot-Marie-Tooth disease was observed in a hereditary motor neuropathy family with a TRPV4 gene mutation. Some gene carriers showed no symptoms, indicating non-penetrance is a feature of TRPV4-related neuropathies.

Area of Science:

  • Genetics
  • Neurology
  • Molecular Biology

Background:

  • Charcot-Marie-Tooth disease (CMT) is a group of inherited peripheral nervous system disorders.
  • Incomplete penetrance, where a genetic mutation does not manifest phenotypically, is rarely documented in CMT.
  • The transient receptor potential vallinoid 4 (TRPV4) gene is implicated in various neuromuscular disorders.

Observation:

  • A multi-generational family with a hereditary motor neuropathy was studied.
  • Two members exhibited distinct phenotypes: moderate facio-scapulo-peroneal syndrome in the proband and severe congenital spinal muscular atrophy with arthrogryposis in her daughter.
  • Three asymptomatic relatives were identified as carriers of a heterozygous Arg269Cys mutation in the TRPV4 gene.

Findings:

  • Clinico-electrophysiological studies and lower-limb MRI confirmed a pure motor axonal neuropathy in affected individuals.
  • Genetic testing identified a heterozygous Arg269Cys mutation in the TRPV4 gene in the affected proband and three asymptomatic carriers.
  • Asymptomatic mutation carriers showed normal clinical, electrophysiological, and imaging results.

Implications:

  • This study highlights reduced penetrance as a significant feature in neuropathic syndromes associated with TRPV4 gene mutations.
  • Understanding non-penetrance is crucial for accurate genetic counseling and diagnosis of hereditary neuropathies.
  • Further research is needed to elucidate the mechanisms underlying variable expressivity and reduced penetrance in TRPV4-related disorders.